(AOF) – Pfizer has agreed to pay $93 million to settle its dispute with wholesale drug distributors who accused it of colluding with Indian laboratories Ranbaxy to delay sales of generic versions of the cholesterol drug Lipitor . According to Reuters, it was lawyers for Lipitor’s buyers who disclosed the deal in a filing Wednesday in U.S. District Court in Trenton, New Jersey. The American laboratory has not admitted its responsibility, and describes the accusations as “unfounded”.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
